La borréliose de Lyme et son diagnostic biologique
Tài liệu tham khảo
Steere, 2016, Lyme borreliosis, Nat Rev Dis Primer, 2, 16090, 10.1038/nrdp.2016.90
Schriefer, 2015, Borrelia, Man Clin Microbiol Elev Ed, 1037, 10.1128/9781555817381.ch59
Burgdorfer, 1982, Lyme disease-a tickborne spirochetosis?, Science, 216, 1317, 10.1126/science.7043737
Adeolu, 2014, Antonie Van Leeuwenhoek, 105, 1049, 10.1007/s10482-014-0164-x
Margos, 2018, The genus Borrelia reloaded, PLoS ONE, 13, 10.1371/journal.pone.0208432
Talagrand-Reboul, 2018, Relapsing Fevers: Neglected Tick-Borne Diseases, Front Cell Infect Microbiol, 8, 10.3389/fcimb.2018.00098
Pritt, 2016, Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study, Lancet Infect Dis, 16, 556, 10.1016/S1473-3099(15)00464-8
Baranton, 2009, Borrelia burgdorferi sensu lato diversity and its influence on pathogenicity in humans, Curr Probl Dermatol, 37, 1, 10.1159/000213066
Grillon, 2018, Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis, Semin Arthritis Rheum
Wang, 1999, Molecular Typing of Borrelia burgdorferi sensu Lato: Taxonomic, Epidemiological, and Clinical Implications, Clin Microbiol Rev, 12, 633, 10.1128/CMR.12.4.633
Réseau Sentinelles > France > Accueil n.d. https://websenti.u707.jussieu.fr/sentiweb/ (accessed April 19, 2019).
Vandenesch, 2014, Incidence and hospitalisation rates of Lyme borreliosis, France, 2004 to 2012, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, 19
Stanek, 2012, Lyme borreliosis, Lancet Lond Engl, 379, 461, 10.1016/S0140-6736(11)60103-7
Boulanger, 2018, Surveillance du vecteur de la borréliose de Lyme, Ixodes ricinus, en Alsace de 2013 à 2016, Bull Epidémiologique Hebd, 400
Bockenstedt, 2014, What Ticks Do Under Your Skin: Two-Photon Intravital Imaging of Ixodes scapularis Feeding in the Presence of the Lyme Disease Spirochete, Yale J Biol Med, 87, 3
Hofhuis, 2017, Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model, PLoS ONE, 12, 10.1371/journal.pone.0181807
Hofhuis, 2013, A prospective study among patients presenting at the general practitioner with a tick bite or erythema migrans in The Netherlands, PloS One, 8, e64361, 10.1371/journal.pone.0064361
Septfons, 2019, Epidemiology of Lyme borreliosis through two surveillance systems: the national Sentinelles GP network and the national hospital discharge database, France, 2005 to 2016, Eurosurveillance, 24, 1800134, 10.2807/1560-7917.ES.2019.24.11.1800134
Oschmann, 2019, Clinical symptoms, Lyme Borreliosis Tick-Borne Enceph. Uni-Med, n.d.,, 52
Raguet S, Schapmann L, Hansmann Y, et al. Étude d’incidence de trois pathologies transmises par les tiques en Alsace, Alsace(tique) 2014-2015 / 2018 / Maladies infectieuses / Rapports et syntheses / Publications et outils / Accueil n.d. http://invs.santepubliquefrance.fr/Publications-et-outils/Rapports-et-syntheses/Maladiesinfectieuses/2018/Etude-d-incidence-de-trois-pathologies-transmisespar-les-tiques-en-Alsace-Alsace-tique-2014-2015 (accessed April 18, 2019).
Stanek, 2009, Lyme borreliosis: a European perspective on diagnosis and clinical management, Curr Opin Infect Dis, 22, 450, 10.1097/QCO.0b013e32832ee880
Hidri, 2012, Lyme endocarditis, Clin Microbiol Infect, 18, 531, 10.1111/1469-0691.12016
Blanc, 2014, Lyme neuroborreliosis and dementia, J Alzheimers Dis JAD, 41, 1087, 10.3233/JAD-130446
Hansen, 2013, Lyme neuroborreliosis, Handb Clin Neurol, 115, 559, 10.1016/B978-0-444-52902-2.00032-1
Kristoferitsch, 1991, Neurological manifestations of Lyme borreliosis: clinical definition and differential diagnosis, Scand J Infect Dis, 77, 64
Hansen, 1992, The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990, A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain J Neurol, 115, 399
Wormser, 2006, The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America, Clin Infect Dis Off Publ Infect Dis Soc Am, 43, 1089, 10.1086/508667
Cerar, 2010, Subjective symptoms after treatment of early Lyme disease, Am J Med, 123, 79, 10.1016/j.amjmed.2009.05.011
Seltzer, 2000, Long-term outcomes of persons with Lyme disease, JAMA, 283, 609, 10.1001/jama.283.5.609
Skogman, 2008, Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome, Pediatr Infect Dis J, 27, 1089, 10.1097/INF.0b013e31817fd423
Cairns, 2005, Post-Lyme borreliosis syndrome: a metaanalysis of reported symptoms, Int J Epidemiol, 34, 1340, 10.1093/ije/dyi129
Knudtzen, 2017, Characteristics and Clinical Outcome of Lyme Neuroborreliosis in a High Endemic Area, 1995-2014: A Retrospective Cohort Study in Denmark, Clin Infect Dis Off Publ Infect Dis Soc Am, 65, 1489, 10.1093/cid/cix568
Berglund, 2002, 5-y Follow-up study of patients with neuroborreliosis, Scand J Infect Dis, 34, 421, 10.1080/00365540110080421
Mygland, 2010, EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis, Eur J Neurol, 17, 8, 10.1111/j.1468-1331.2009.02862.x
Stanek, 2011, Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe, Clin Microbiol Infect, 17, 69, 10.1111/j.1469-0691.2010.03175.x
Goettner, 2005, Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues, J Clin Microbiol, 43, 3602, 10.1128/JCM.43.8.3602-3609.2005
Hunfeld, 2009, When Is the Best Time to Order a Western Blot and How Should It Be Interpreted?, Lyme Borreliosis, 37, 167, 10.1159/000213074
Hauser, 1999, Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe, J Clin Microbiol, 37, 2241, 10.1128/JCM.37.7.2241-2247.1999
Wilske, 2007, Microbiological and serological diagnosis of Lyme borreliosis, FEMS Immunol Med Microbiol, 49, 13, 10.1111/j.1574-695X.2006.00139.x
Harrer, 2007, Seronegative Lyme neuroborreliosis in a patient on treatment for chronic lymphatic leukemia, Infection, 35, 110, 10.1007/s15010-007-6121-0
Ryan, 2013, Lyme Carditis in an Immunocompromised Patient, Case Rep Emerg Med, 2013
Dop, 2013, Seronegative lyme neuroborreliosis in a patient using rituximab, Case Rep, 2013
Dessau, 2018, To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis, Clin Microbiol Infect, 24, 118, 10.1016/j.cmi.2017.08.025
Seriburi, 2012, High frequency of false positive IgM immunoblots for Borrelia burgdorferi in Clinical Practice, Clin Microbiol Infect, 18, 1236, 10.1111/j.1469-0691.2011.03749.x
Kalish, 2001, Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses to Borrelia burgdorferi 10.20 Years after Active Lyme Disease, Clin Infect Dis, 33, 780, 10.1086/322669
Peltomaa, 2003, Persistence of the Antibody Response to the VlsE Sixth Invariant Region (IR6) Peptide of Borrelia burgdorferi after Successful Antibiotic Treatment of Lyme Disease, J Infect Dis, 187, 1178, 10.1086/374376
Schmidt, 2011, A prospective study on the role of CXCL13 in Lyme neuroborreliosis, Neurology, 76, 1051, 10.1212/WNL.0b013e318211c39a
Dessau, 2016, Microscopy of human blood for Borrelia burgdorferi and Babesia without clinical or scientific rationale, Infect Dis, 48, 420, 10.3109/23744235.2016.1144932
Li, 2011, Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis, Arthritis Rheum, 63, 2238, 10.1002/art.30384